Zhang Xiaohui, Shou Zhangfei, Chen Zhimin, Xu Ying, Han Fei, Yin Xiaohong, Lin Jun, Pan Haiyan, He Peipei, Chen Jianghua
Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, P.R. China.
Perit Dial Int. 2014 Jun;34 Suppl 2(Suppl 2):S55-8. doi: 10.3747/pdi.2013.00124.
Peritoneal dialysis plays a crucial role in the integrated care of patients with end-stage renal disease (ESRD). In this paper, we retrospectively analyzed the quality indicators of peritoneal dialysis (PD) in 712 patients from our center who underwent PD between 2004 and 2011. In 43% of patients, follow-up was undertaken every 3 months at our outpatient department, and 54% patients were followed up by both our hospital and other local hospitals. The patient survival rate at 1, 3 and 5 years was 96.3%, 85.4% and 76.2%, respectively. The technique survival (excludes death/transplantation) at 1, 3 and 5 years was 95.1%, 87.7% and 79.6%, respectively. Fluid overload occurred in 29.2% of patients and was one of the major reasons for discontinuing PD. The peritonitis rate in our center decreased to 0.16 episodes/year in 2011. In addition, since our center is one of the largest integrated-treatment centers for ESRD in China, we have developed a multilevel care program in Zhejiang Province, which resulted in rapid growth of PD in our province in recent years.
腹膜透析在终末期肾病(ESRD)患者的综合治疗中起着关键作用。在本文中,我们回顾性分析了2004年至2011年间在我们中心接受腹膜透析(PD)的712例患者的腹膜透析质量指标。43%的患者在我们门诊部每3个月进行一次随访,54%的患者由我们医院和当地其他医院共同随访。1年、3年和5年的患者生存率分别为96.3%、85.4%和76.2%。1年、3年和5年的技术生存率(不包括死亡/移植)分别为95.1%、87.7%和79.6%。29.2%的患者出现液体超负荷,这是停止腹膜透析的主要原因之一。2011年我们中心的腹膜炎发生率降至0.16次/年。此外,由于我们中心是中国最大的ESRD综合治疗中心之一,我们在浙江省制定了一项多层次护理计划,这导致近年来我省腹膜透析快速增长。